Cargando…
Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
BACKGROUND: “Vision 2020 – the right to sight” is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete action plans at the national and district levels. Accordingly, baseline data are needed for the planning, monitoring, follow-up and ev...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392737/ https://www.ncbi.nlm.nih.gov/pubmed/25866740 http://dx.doi.org/10.1186/s40200-015-0151-4 |
_version_ | 1782366040047484928 |
---|---|
author | Jingi, Ahmadou M Nansseu, Jobert Richie N Noubiap, Jean Jacques N Bilong, Yannick Ellong, Augustin Mvogo, Côme Ebana |
author_facet | Jingi, Ahmadou M Nansseu, Jobert Richie N Noubiap, Jean Jacques N Bilong, Yannick Ellong, Augustin Mvogo, Côme Ebana |
author_sort | Jingi, Ahmadou M |
collection | PubMed |
description | BACKGROUND: “Vision 2020 – the right to sight” is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete action plans at the national and district levels. Accordingly, baseline data are needed for the planning, monitoring, follow-up and evaluation of this program. The present study aimed to better characterize visual impairment and blindness in Cameroonian diabetics by providing with baseline data on the prevalence and main causes of these affections. METHODS: This was a hospital-based cross-sectional study, conducted from October 2004 to October 2006 at the Department of Ophthalmology of the Douala General Hospital, Cameroon. We included 407 diabetic patients who were referred from diabetes clinics for ophthalmologic evaluation. Ophthalmologic data included visual acuity, intra-ocular pressure, fundoscopy and fluorescein angiography. RESULTS: The prevalence of blindness and poor vision were respectively 12.3% and 17.4% with regard to the worst eyes. Fifty nine (14.5%) patients were found with diabetic maculopathy, of whom 25.4% (15/59) had poor vision, and 25.4% (15/59) were blind. The prevalence of sight threatening retinopathy (severe non-proliferative and proliferative) was 17.4%. The degree of visual impairment was comparable in both diabetic types (p = 0.825), and it increased with the severity of retinopathy (p < 0.0001), as well as that of maculopathy (p <0.0001). The prevalence of glaucoma was 15% (61/407) when considering the worst eyes. The severity of visual impairment increased with the severity of glaucoma (p = 0.001). One hundred and twenty-one (29.7%) patients presented with cataract irrespective of its location or severity. Cataract was significantly associated with poor vision and blindness (p < 0.0001). Hypertensive retinopathy (4.9%), papillary ischaemia (2.7%), vaso-occlusive eye disease (2.5%), and age-related macular edema (2%) were the other potential causes of visual impairment and blindness encountered the most in our setting. Age ≥ 50 years, male sex, duration of diabetes and hypertension variously increased the risk of having glaucoma, cataract, diabetic retinopathy or maculopathy. CONCLUSION: Poor vision and blindness are frequent in Cameroonian diabetics, and their causes are similar to those reported by various other surveys: mainly cataract, glaucoma, diabetic retinopathy and maculopathy. |
format | Online Article Text |
id | pubmed-4392737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43927372015-04-11 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon Jingi, Ahmadou M Nansseu, Jobert Richie N Noubiap, Jean Jacques N Bilong, Yannick Ellong, Augustin Mvogo, Côme Ebana J Diabetes Metab Disord Research Article BACKGROUND: “Vision 2020 – the right to sight” is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete action plans at the national and district levels. Accordingly, baseline data are needed for the planning, monitoring, follow-up and evaluation of this program. The present study aimed to better characterize visual impairment and blindness in Cameroonian diabetics by providing with baseline data on the prevalence and main causes of these affections. METHODS: This was a hospital-based cross-sectional study, conducted from October 2004 to October 2006 at the Department of Ophthalmology of the Douala General Hospital, Cameroon. We included 407 diabetic patients who were referred from diabetes clinics for ophthalmologic evaluation. Ophthalmologic data included visual acuity, intra-ocular pressure, fundoscopy and fluorescein angiography. RESULTS: The prevalence of blindness and poor vision were respectively 12.3% and 17.4% with regard to the worst eyes. Fifty nine (14.5%) patients were found with diabetic maculopathy, of whom 25.4% (15/59) had poor vision, and 25.4% (15/59) were blind. The prevalence of sight threatening retinopathy (severe non-proliferative and proliferative) was 17.4%. The degree of visual impairment was comparable in both diabetic types (p = 0.825), and it increased with the severity of retinopathy (p < 0.0001), as well as that of maculopathy (p <0.0001). The prevalence of glaucoma was 15% (61/407) when considering the worst eyes. The severity of visual impairment increased with the severity of glaucoma (p = 0.001). One hundred and twenty-one (29.7%) patients presented with cataract irrespective of its location or severity. Cataract was significantly associated with poor vision and blindness (p < 0.0001). Hypertensive retinopathy (4.9%), papillary ischaemia (2.7%), vaso-occlusive eye disease (2.5%), and age-related macular edema (2%) were the other potential causes of visual impairment and blindness encountered the most in our setting. Age ≥ 50 years, male sex, duration of diabetes and hypertension variously increased the risk of having glaucoma, cataract, diabetic retinopathy or maculopathy. CONCLUSION: Poor vision and blindness are frequent in Cameroonian diabetics, and their causes are similar to those reported by various other surveys: mainly cataract, glaucoma, diabetic retinopathy and maculopathy. BioMed Central 2015-04-08 /pmc/articles/PMC4392737/ /pubmed/25866740 http://dx.doi.org/10.1186/s40200-015-0151-4 Text en © Jingi et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Jingi, Ahmadou M Nansseu, Jobert Richie N Noubiap, Jean Jacques N Bilong, Yannick Ellong, Augustin Mvogo, Côme Ebana Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon |
title | Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon |
title_full | Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon |
title_fullStr | Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon |
title_full_unstemmed | Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon |
title_short | Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon |
title_sort | diabetes and visual impairment in sub-saharan africa: evidence from cameroon |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392737/ https://www.ncbi.nlm.nih.gov/pubmed/25866740 http://dx.doi.org/10.1186/s40200-015-0151-4 |
work_keys_str_mv | AT jingiahmadoum diabetesandvisualimpairmentinsubsaharanafricaevidencefromcameroon AT nansseujobertrichien diabetesandvisualimpairmentinsubsaharanafricaevidencefromcameroon AT noubiapjeanjacquesn diabetesandvisualimpairmentinsubsaharanafricaevidencefromcameroon AT bilongyannick diabetesandvisualimpairmentinsubsaharanafricaevidencefromcameroon AT ellongaugustin diabetesandvisualimpairmentinsubsaharanafricaevidencefromcameroon AT mvogocomeebana diabetesandvisualimpairmentinsubsaharanafricaevidencefromcameroon |